XIGDUO XR不应用于活动性膀胱癌患者。对有膀胱癌病史的患者慎用。 宏观血管结果:目前还没有临床研究证实XIGDUO XR能够显着降低大血管风险。 不良反应 达帕格列净(5 mg或10 mg)加二甲双胍与安慰剂加二甲双胍的最常见不良反应(≥5%)为...
(XIGDUO XR 5 mg/1,000 mg), the equivalent of 10 mg dapagliflozin as dapagliflozin propanediol and 500 mg metformin HCL which is equivalent to 389.9 mg metformin base (XIGDUO XR 10 mg/500 mg), or the equivalent of 10 mg dapagliflozin as dapagliflozin propanediol and 1,000 mg metformin HCL...
If taking an evening dose of metformin XR, skip last dose before starting dapagliflozin/metformin Adjust dose based on effectiveness and tolerability; not to exceed daily dose of dapagliflozin 10 mg and metformin 2000 mg Before initiating Assess renal function before initiating and periodically thereaf...
Xigduo Xr Prices This drug has some additional restrictions. Learn More Tablet I And Extend R Biphase 24hr, 2.5-1000mg, 30 Tablet I And Extend R Biphase 24hrs (Edit) Set Your Location for prices near you. PUBLIX $ 300.29 WALGREENS $ 300.29 CVS $ 325.39 WAL-MART $ 294.79 RITE ...
(XIGDUO XR 5 mg/1000 mg), the equivalent of 10 mg dapagliflozin as dapagliflozin propanediol and 500 mg metformin hydrochloride (XIGDUO XR 10 mg/500 mg), or the equivalent of 10 mg dapagliflozin as dapagliflozin propanediol and 1000 mg metformin hydrochloride (XIGDUO XR 10 mg/1000 mg). ...
10 mg dapagliflozin/1000 mg metformin extended-release oral tablets How should I store Xigduo XR? Xigduo XR oral tablets should be stored at room temperature, between 68 F to 77 F (20 C to 25 C). It can be exposed to temperatures between 59 F to 86 F (15 C to 30 C) for shorter...
001XIGDUO XRDAPAGLIFLOZIN; METFORMIN HYDROCHLORIDETABLET, EXTENDED RELEASE;ORAL5MG;500MGYesNoNone2014/10/292014/10/29Prescription 002XIGDUO XRDAPAGLIFLOZIN; METFORMIN HYDROCHLORIDETABLET, EXTENDED RELEASE;ORAL5MG;1GMYesNoNone2014/10/29Prescription
产地国家:瑞士处 方药:是所属类别:5mg毫克/500毫克/片 28片/盒包装规格:5mg毫克/500毫克/片 28片/盒计价单位:盒生产厂家中文参考译名:AstraZeneca AG生产厂家英文名:AstraZeneca AG原产地英文商品名:Xigduo XR Filmtabletten 5mg/1000mg 28Stück原产地英文药品名:dapagliflozin/metformin中文参考商品译名:Xigduo缓释薄...
宏观血管结果:目前还没有临床研究证实XIGDUO XR能够显着降低大血管风险。 不良反应 达帕格列净(5 mg或10 mg)加二甲双胍与安慰剂加二甲双胍的最常见不良反应(≥5%)为女性生殖器真菌感染(9.4%,9.3%,1.5%),鼻咽炎(6.3%,5.2%, 5.9%),尿路感染(6.1%,5.5%,3.6%),腹泻(5.9%,4.2%,5.6%)和头痛(5.4%,3.3%...